Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 9/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.36 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26732432 | 1.00 | NLRP3 (0.55) | NLRP3KMT2ACHRNA7RAB9AKDM4E | |
| SCHEMBL24077283 | 1.00 | NLRP3 (0.55) | NLRP3KMT2ACHRNA7RAB9AKDM4E | |
| SCHEMBL24077225 | 1.00 | NLRP3 (0.55) | NLRP3KMT2ACHRNA7RAB9AKDM4E | |
| SCHEMBL26732250 | 0.97 | NLRP3 (0.59) | NLRP3KMT2ACHRNA7RAB9A | |
| SCHEMBL25746344 | 0.90 | NLRP3 (0.56) | NLRP3KMT2ACHRNA7RAB9A | |
| SCHEMBL26732289 | 0.88 | NLRP3 (0.61) | NLRP3KMT2ACHRNA7RAB9AKDM4E | |
| SCHEMBL24076301 | 0.88 | NLRP3 (0.54) | NLRP3KMT2ACHRNA7RAB9A | |
| SCHEMBL29426532 | 0.88 | NLRP3 (0.54) | NLRP3KMT2ACHRNA7RAB9A | |
| SCHEMBL25746454 | 0.88 | NLRP3 (0.54) | NLRP3KMT2ACHRNA7RAB9A | |
| SCHEMBL25751191 | 0.88 | NLRP3 (0.54) | NLRP3KMT2ACHRNA7RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116261456-A | Compounds, compositions, and methods | 戴纳立制药公司 | 2023-06-13 | — | — | CN | disclosed |